Infantile Spasm Epidemiology Forecast

DelveInsight's 'Infantile Spasm - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Infantile Spasm epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Infantile Spasm Understanding

The DelveInsight Infantile Spasm epidemiology report gives a thorough understanding of the Infantile Spasm by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Infantile Spasm in the US, Europe, and Japan. The report covers the detailed information of the Infantile Spasm epidemiology scenario in seven major countries (US, EU5, and Japan).


Infantile Spasm Epidemiology Perspective by DelveInsight

The Infantile Spasm epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Infantile Spasm epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Infantile Spasm epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Infantile Spasm Detailed Epidemiology Segmentation

The Infantile Spasm epidemiology covered in the report provides historical as well as forecasted Infantile Spasm epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Infantile Spasm report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Infantile Spasm report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Infantile Spasm Epidemiology Report and Model provide an overview of the risk factors and global trends of Infantile Spasm in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Infantile Spasm in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Infantile Spasm
  • The report provides the segmentation of the Infantile Spasm epidemiology


Report Highlights

  • 11-Year Forecast of Infantile Spasm epidemiology
  • 7MM Coverage
  • Total Cases of Infantile Spasm
  • Total Cases of Infantile Spasm according to segmentation
  • Diagnosed cases of Infantile Spasm


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Infantile Spasm?
  • What are the key findings pertaining to the Infantile Spasm epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Infantile Spasm across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Infantile Spasm?
  • What are the currently available treatments of Infantile Spasm?


Reasons to buy

  • The Infantile Spasm Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Infantile Spasm market
  • Quantify patient populations in the global Infantile Spasm market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Infantile Spasm therapeutics in each of the markets covered
  • Understand the magnitude of Infantile Spasm population by its epidemiology
  • The Infantile Spasm Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Infantile Spasm

3. Infantile Spasm: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Infantile Spasm Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Infantile Spasm Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Infantile Spasm Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Infantile Spasm Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Infantile Spasm Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Infantile Spasm Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Infantile Spasm Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Infantile Spasm Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Infantile Spasm Treatment and Management

6.2. Infantile Spasm Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Infantile Spasm Epidemiology in 7MM (2017-2030)

Table 2 Infantile Spasm Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Infantile Spasm Epidemiology in the United States (2017-2030)

Table 4 Infantile Spasm Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Infantile Spasm Epidemiology in Germany (2017-2030)

Table 6 Infantile Spasm Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Infantile Spasm Epidemiology in France (2017-2030)

Table 8 Infantile Spasm Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Infantile Spasm Epidemiology in Italy (2017-2030)

Table 10 Infantile Spasm Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Infantile Spasm Epidemiology in Spain (2017-2030)

Table 12 Infantile Spasm Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Infantile Spasm Epidemiology in the United Kingdom (2017-2030)

Table 14 Infantile Spasm Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Infantile Spasm Epidemiology in Japan (2017-2030)

Table 16 Infantile Spasm Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Infantile Spasm Epidemiology in 7MM (2017-2030)

Figure 2 Infantile Spasm Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Infantile Spasm Epidemiology in the United States (2017-2030)

Figure 4 Infantile Spasm Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Infantile Spasm Epidemiology in Germany (2017-2030)

Figure 6 Infantile Spasm Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Infantile Spasm Epidemiology in France (2017-2030)

Figure 8 Infantile Spasm Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Infantile Spasm Epidemiology in Italy (2017-2030)

Figure 10 Infantile Spasm Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Infantile Spasm Epidemiology in Spain (2017-2030)

Figure 12 Infantile Spasm Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Infantile Spasm Epidemiology in the United Kingdom (2017-2030)

Figure 14 Infantile Spasm Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Infantile Spasm Epidemiology in Japan (2017-2030)

Figure 16 Infantile Spasm Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Infantile Spasm Epidemiology
  • Infantile Spasm
  • Infantile Spasm Pipeline
  • Infantile Spasm Companies
  • Infantile Spasm prevalent populati...
  • Infantile Spasm incident populatio...
  • Infantile Spasm patients diagnosed
  • Infantile Spasm treatment algorith...

Forward to Friend

Need A Quote